Available online on 15.01.2026 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2026 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Case Reoprt
Effect of Habb-e-Gule-Aak (Unani pharmacopeial compound formulation) and Riyazat in the management of Non-specific Low back pain (Waja’ uz-Zahr): A Case series
Sadaf T.A. Shaikh 1, Mohd. Anwar 2, Mohammad Saad Ahmad Khan 3
1 PG Scholar. Dept. of Ilaj Bit Tadbeer, F/o Unani Medicine, AMU, Aligarh;
2 Professor. Dept. of Ilaj Bit Tadbeer, F/o Unani Medicine, AMU, Aligarh;
3 Assistant Professor. Dept. of Ilaj Bit Tadbeer, F/o Unani Medicine, AMU, Aligarh.
|
Article Info: _______________________________________________ Article History: Received 18 Oct 2025 Reviewed 27 Nov 2025 Accepted 21 Dec 2025 Published 15 Jan 2026 _______________________________________________ Cite this article as: Shaikh STA, Anwar M, Khan MSA, Effect of Habb-e-Gule-Aak (Unani pharmacopeial compound formulation) and Riyazat in the management of Non-specific Low back pain (Waja’ uz-Zahr): A Case series, Journal of Drug Delivery and Therapeutics. 2026; 16(1):5-9 DOI: http://dx.doi.org/10.22270/jddt.v16i1.7526 _______________________________________________ For Correspondence: Sadaf T.A. Shaikh, PG Scholar. Dept of Ilaj Bit Tadbeer, AKTC, AMU, Aligarh. |
Abstract _______________________________________________________________________________________________________________ Background: Low back pain has been a significant public health issue since long time, resulting in loss of functional productivity and medical costs. Nonspecific low back pain (NSLBP) or pain for which there is no known cause, affects about 85% of sufferers. Although there are conservative treatments accessible in the conventional medical system, like NSAIDs, which produces certain side effects. Unani system of medicine is the ancient system of medicine which deals with prophylactic and therapeutic management of many illnesses with no or least adverse effects. Objectives: To evaluate the effect of Unani compound pharmacopeial drug i.e., Habb-e-Gule-Aak (HGA) and exercises of lumbo-pelvic muscles (strengthening and stretching) in the management of NSLBP. Materials and Methods: Five patients with a primary report of chronic NSLBP (>6 months) without radiculopathy were treated with 2 pills of HGA twice daily for 30 days. The effectiveness of therapy was assessed on baseline, 15th day and 30th day using a numeric rating scale (NRS) to measure pain reduction and Oswestry disability index (ODI) to assess the decrease in lower back disability in NSLBP. Results: HGA and exercises of lumbo-pelvic muscles (strengthening and stretching) significantly reduced pain and disability in NSLBP. Conclusion: This case series is preliminary research of the use of multiple modalities in the management of NSLBP. It is envisaged that additional experimental research will be done to demonstrate the efficacy of this combination in treating people with NSLBP. Keywords: Habb-e-Gule-Aak, Ilaj Bit Tadbir, Lower back Exercise, Non-Specific Low back pain, Unani medicine |
Introduction
The most prevalent kind of musculoskeletal disorders associated with the spine is low back pain, which affects 84% of people. Additionally, 23% of all occurrences of low back pain are found to have chronic low back pain, which is low back pain that is untreated and lasts longer than 12 weeks1. According to Ribeiro et al. (2018), over 85% of chronic low back pain has no known cause or diagnosis and is categorized as chronic non-specific low back pain. The term "non-specific low back pain" (NSLBP) refers to a type of low back pain that is not caused by a specific pathology (such as osteoporosis, radicular syndrome, tumor, structural deformity, infection such as pott’s spine, or cauda equina syndrome)2. It is usually defined as pain, muscle tension, or stiffness localised below the costal margin and above the inferior gluteal folds. The most important symptoms of non-specific low back pain are pain and disability3. The term Waja’ uz-Zahr is used to describe the Low back pain under the broad heading Waja’ al-Mafasil in Unani medicine. Hakim Ghulam Jeelani (20th century) described different causative factors of Waja-uz-Zahr such as Takan, Laghri and excessive labour etc. He stated that the main causes of Waja’ uz-Zahr and Waja’ al-Mafasil is the Kham Madda (morbid matter) which gets accumulated of in joint spaces4. Eminent Unani physicians described a number of treatments including pharmacological and non-pharmacological approaches under two essential modes i.e., ‘Ilaj Bit Tadbir (Regimenal therapy) and ‘Ilaj bi’d Dawa’ (pharmacotherapy) in the management of NSLBP in their manuscripts such as Zarawand, Hulba, Tukm-e-karafs, Habb-ul-rshad, Ajwain, Darchini, Zanjbeel, Ushq, Sakbeenaj, Anzroot, Hilliyoon, Suranjan, Sibr, Hijamah (Cupping therapy), Takmeed (fomentations), Dalk (Massage therapy), Riyazat (Exercise therapy) and Inkebab (steam therapy) etc5,6. There is some evidence that analgesics, antidepressants and nonsteroidal anti-inflammatory medications are helpful treatments in NSLBP. Other therapies (such as steroid injections, lumbar supports, and traction) are not supported by any research7. Dyspepsia or vomiting to more serious injuries including gastroduodenal ulceration, bleeding, and gastrointestinal lesions are among the GI system side effects associated with the use of NSAIDs8. Additionally, several studies have shown hepatotoxicity9-11. Due to these significant adverse effects of pharmacological medications in conventional medicine an attempt has been made to evaluate the effects of Habb-e-Gule-Aak (Unani pharmacopeial compound formulation) and Riyazat in the management of Non-specific Low back pain (Waja’ uz-Zahr).
Habb-e-Gul-e-Aak (HGA), a polyherbal pharmaceutical drug (pills), is mentioned in almost all pharmacopoeias, formularies, and Qarabadeen in Unani system of medicine. It has been used for a long time to treat inflammatory disorders, both acute and chronic, although it has been noted to be most beneficial in chronic conditions, particularly those affecting the joints and bones, such as Waja’ al-Mafasil, Niqris, Waja’ al-Warik, etc. Available literature state that it is an effective drug for treating Waja’ al-Mafasil patients12-14. Hippocrates, father of medicine, wrote in the fifth century BC: "All parts of the body, if used in moderation and exercised in labours to which each is accustomed, become thereby healthy and well developed and age slowly; but if they are unused and left idle, they become liable to disease, defective in growth, and age quickly." Several ancient Unani Scholars, including Hippocrates, Galen, Razi, and Avicenna, wrote about the curative properties of Riyazat. Riyazat is an action that is taken voluntarily with the intent of Tanqiyae mawad (evacuating waste material). It is crucial for both the preservation of health and the avoidance of sickness, as well as the treatment of some illnesses15,16. When joint mobilization is used to treat NSLBP, the distribution of synovial fluid in the joint cartilages and disc improves, which results in lessening the resistance to joint movement17. Additionally, lumbopelvic stabilization training improves motor control in NSLBP by stabilizing the muscles responsible for maintaining posture18. Patients with LBP have showed pain relief from stretching exercises involving the lumbopelvic supporting muscles, such as the gluteal, hamstring, and quadriceps muscles19.
2. Materials and Methods
2.1 Inclusion Criteria
Five patients selected from the OPD of Ajmal Khan Tibbia College, AMU, Aligarh with the persistent LBP as their primary complaint were assessed. Patients having a primary report of LBP (between T12 and the gluteal fold) qualified as inclusion criteria for the present study. Age between 18 and 65, low back pain without radiating below the knee from 6 months or more than 6 months duration, and a modified Oswestry disability index (ODI) score of greater than 30.
2.2 Exclusion Criteria
Patients on surgical or non-surgical management within the past six months, signs of nerve root compression (muscle weakness, hyporeflexia, and paresthesia), and any medical red flags such as tumor, vertebral fracture, osteoporosis, prolonged history of steroid use, ankylosing spondylitis, severe liver disorders and kidney impairments were excluded.
2. Procedure of application of Interventions
Five patients selected from the OPD of Ajmal Khan Tibbia College, AMU, Aligarh with the complaints of pain over lower back which aggravates during prolonged sitting, bending and walking from last 6 months to 2 years. On examination there are restriction in movements without local tenderness and swelling. Patients had no history of metabolic disease, hypertension and tuberculosis. On general examination their vitals were within normal limit and no abnormality was detected through systemic examination. Habb-e-Gule-Aak (HGA) prepared in the Ajmal Khan Tibbia College dawakhana as per the guidelines of the Bayaz-e-Kabeer, Vol. 112. HGA 2 pills has been given twice daily for 30 days. Information about ethnopharmacological properties of ingredients of Habb-e-Gule-Aak are listed in table1. Patients have been explained about strengthening and stretching of lumbo-pelvic muscles. Four exercises have been selected for this case series (1) supine abdominal draw-in (2) double leg bridge (3) side plank static holds (4) prone bridging on elbows with single leg hip extension. All exercises have been advised for 10 repetitions twice daily20.
Table 1: Ethnopharmacological properties of ingredients Habb-e-Gule-Aak
|
Botanical names |
Unani names |
Therapeutically active constituents |
Effects as per Unani Medicine |
Associated Pharmacological activity |
|
Calotropis procera |
Gul-e-Aak |
calotropenyl acetate |
Muhallil (anti-inflammatory), Musakkin (analgesic)21,22 |
Anti-inflammatory, Analgesic23 |
|
Zingiber officinale Rosc. |
Zanjabeel |
Gingerols, (6)-Shogaol, zingiberene, [6]-gingerol |
Muhallil (anti-inflammatory), Musakkin (analgesic)24 |
Antiarthritic, Anti-inflammatory, antioxidant25-27 |
|
Bambusa arundinacea Retz |
Barg-e- Bans |
Arginine, cysteine, histidine |
Musakkin (analgesic)28 |
Anti-inflammatory, Antiarthritic29,30 |
|
Piper nigrum Linn |
Filfil siyah |
Piperine, Dihydro-pipericide |
Musakkin (analgesic), Muhallil (anti-inflammatory)31 |
Antiarthritic, Anti-inflammatory, Analgesic32 |
3. Case presentation
3.1 Case report 1
A 34 years old male with a history of severe, intermittent low back pain since eight months with a chief complaint of non-radiating low back pain. He was assessed on NRS and found the score 7 on 10 points Likert’s scale, pain aggravated while bending and climbing stairs. His ODI score was 52 (severe disability).
3.2 Case report 2
A 26 years old female with a history of severe, intermittent low back pain since 1 year with a chief complaint of non-radiating low back pain. She was assessed on NRS and found the score 5 on 10 points Likert’s scale, with severe pain while bending and climbing stairs. His ODI score was 36 (moderate disability).
3.3. Case report 3
A 61 years old female with a history of low back pain which was non radiating in nature since 6 months. Pain was started after prolonged travelling. Pain score was 4 at NRS and ODI was 48 (severe disability).
3.4. Case report 4
A 47 years old female with a history of low back pain which was non radiating in nature started after lifting heavy weight since 2 years. Pain was started after prolonged travelling. Pain score was 8 at NRS and ODI was 57 (severe disability).
3.5. Case report 5
A 20 years old female student with a history of low back pain which was non radiating in nature aggravated by prolonged sitting since 18 months. Pain score was 6 at NRS and ODI was 41 (moderate disability).
4. Results
Low Back pain was assessed according to NRS and ODI on baseline, 15th and 30th day. As depicted in Table 2, NRS score in Case 1 was 7 at baseline, 5 on fifteenth day and 2 on thirtieth day. NRS score in Case 2 was 5 at baseline, 4 on fifteenth day and 3 on thirtieth day. NRS score in Case 3 was 4 at baseline, 2 on fifteenth day and 1 on thirtieth day. In Case 4, NRS score was 8 at baseline, 6 on fifteenth day and 3 on thirtieth day. In Case 5, NRS score was 6 at baseline, 5 on fifteenth day and 3 on thirtieth day. ODI score in Case 1 was 52 at baseline, 43 on fifteenth day and 38 on thirtieth day. In Case 2, ODI score was 36 at baseline, 28 on fifteenth day and 20 on thirtieth day. In Case 3, ODI score was 48 at baseline, 39 on fifteenth day and 21 on thirtieth day. In Case 4, ODI score was 57 at baseline, 43 on fifteenth day and 31 on thirtieth day. In Case 5, ODI score was 41 at baseline, 32 on fifteenth day and 19 on thirtieth day (Figure 1& 2).
Table 2. Efficacy of Interventions on NRS
|
Parameters |
Numeric Rating Scale (NRS) |
|||||
|
Case1 |
Case2 |
Case3 |
Case4 |
Case5 |
Mean±S.D |
|
|
Baseline |
7 |
5 |
4 |
8 |
6 |
6±1.58 |
|
15th day |
5 |
4 |
2 |
6 |
5 |
4.4±1.51 |
|
30th day |
3 |
4 |
2 |
5 |
4 |
3.6±1.14 |
|
Improvement in percentage |
57% |
40% |
50% |
37.5% |
33.3% |
|
Figure 1: Efficacy of intervention on NRS
Table 3: Efficacy of Interventions on ODI
|
Parameters |
Oswestry disability index (ODI) |
|||||
|
|
Case1 |
Case2 |
Case3 |
Case4 |
Case5 |
Mean±S.D. |
|
Baseline |
52 |
36 |
48 |
57 |
41 |
46.8±8.4 |
|
15th day |
43 |
28 |
39 |
43 |
32 |
38±8.0 |
|
30th day |
38 |
20 |
21 |
31 |
19 |
25.8±8.3 |
|
Improvement in percentage |
26.9% |
44.4% |
56.2% |
45.6% |
53.6% |
|
Figure 2: Efficacy of intervention on ODI
Discussion
Low back pain, which affects 84% of people, is the type of musculoskeletal disorder that is related with the spine. A form of low back pain that is not caused by a specific pathology is referred to as "non-specific low back pain" (NSLBP). The adverse effects of commonly given drugs, such as NSAIDs for the treatment of pain, are well documented. Unani medicine is an ancient approach that can heal many diseases with minimal or no adverse effects. The Unani system of medicine is a traditional medical practice that focuses on the prevention and treatment of various illnesses. Under the umbrella term Waja' al-Mafasil, low back pain is referred to as Waja' uz-Zahr in Unani medicine. HGA, a pill form of the polyherbal Unani medication. Although it has been reported to be most helpful in chronic musculoskeletal disorders. Hippocrates, Galen, Razi, and Avicenna were a few of the early Unani scholars who wrote about Riyazat's therapeutic benefits. Patients with LBP have reported pain reduction from stretches and exercises that target the gluteal, hamstring, and quadriceps muscles, which support the lumbopelvic region20. In the present case series HGA and Riyazat have been implicated in the management of NSLBP. The outcome measures NRS and ODI have been used for the assessment of the improvement in signs and symptoms at baseline, 15th and 30th day. On the analysis, there is significant reduction in the signs and symptoms has been noted. The positive effects noticed in this study were due to the synergistic effects of HGA and strengthening and stretching exercise of lumbopelvic muscles. Significant anti-inflammatory activity was present in the ethanol extract of the flowers of Calotropis procera23. The methanol extract of Bambusa arundinacea's leaves has been investigated and found to have anti-inflammatory effects29. Piperine's analgesic efficacy in mice was assessed was found significantly effective31. Zingiber officinale dense extract was found to have strong antinociceptive and anti-inflammatory effects on the model of AITC-induced inflammation in mice, Additionally, the antiarthritic properties of ginger and its bioactive ingredients were evaluated25,33.
Conclusion
This case series is preliminary multimodal research in the management of NSLBP. Based on this case series, it can be stated that lumbopelvic strengthening and stretching exercises combined with Unani drug formulation are effective in lowering NSLBP pain and disabilities. It is envisaged that additional experimental and clinical research should be carried out in order to demonstrate the efficacy of this combination in treating patients of NSLBP.
Conflict of Interest: The authors declare no potential conflict of interest concerning the contents, authorship, and/or publication of this article.
Author Contributions: All authors have equal contributions in the preparation of the manuscript and compilation.
Source of Support: Nil
Funding: The authors declared that this study has received no financial support.
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: The data presented in this study are available on request from the corresponding author.
Ethical approval: Not applicable.
References
1. Gunnar BJ Andersson, Epidemiological features of chronic low-back pain, The Lancet, Volume 354, Issue 9178; 1999: 581-585. https://doi.org/10.1016/S0140-6736(99)01312-4 PMid:10470716
2. Ribeiro, R. P., Sedrez, J. A., Candotti, C. T., & Vieira, A. Relação entre a dor lombar crônica não específica com a incapacidade, a postura estática e a flexibilidade. Fisioterapia e Pesquisa, 25(4), 2018: 425-431. https://doi.org/10.1590/1809-2950/18001925042018
3. Cherkin DC, Deyo RA, Wheeler K, Ciol M. Physician variation in diagnostic testing for low back pain: who you see is what you get. Arthritis Rheum 1994;37:15-22. https://doi.org/10.1002/art.1780370104 PMid:8129759
4. Jeelani GH, Makhzanul hikmat. New delhi: Aijaz publication house, 1994:264-265.
5. Nayab M, Anwar M, Qamri MA. Clinical study of waja ul Mafasil and evaluation of efficacy of Hijamat-Bila-Shart in the treatment. Indian J Tradit Knowl 2011;10:697-701.
6. Razi., Al Havi Fit Tibb. (Urdu translation by CCRUM) Ministry of Health and Family Welfare, Govt. of Indai, New Delhi 1997:75- 85
7. Van Tulder MW, Koes BW. Low back pain: chronic. Clinical Evidence. London: BMJ Publishing Group, 2006. https://doi.org/10.1016/B0-443-07287-6/50051-5
8. Singh G. NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System. The Journal of rheumatology. Supplement. 1998 May 1;51:8-16.
9. Brun J, Jones R. Nonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problem. The American journal of medicine. 2001 Jan 8;110(1):S12-3. https://doi.org/10.1016/S0002-9343(00)00629-X PMid:11165989
10. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. Bmj. 2006 Jun 1;332(7553):1302-8. https://doi.org/10.1136/bmj.332.7553.1302 PMid:16740558 PMCid:PMC1473048
11. Vonkeman HE, Brouwers JR, van de Laar MA. Understanding the NSAID related risk of vascular events. Bmj. 2006 Apr 13;332(7546):895-8. https://doi.org/10.1136/bmj.332.7546.895 PMid:16613964 PMCid:PMC1440616
12. Kabeeruddin H.M. Bayaz-e-Kabeer, Vol. I, Hikmat Book Depo, Hyderabad 1925: 275.
13. Anonymous,. Qarabadeen-e-Hamdard, Hamdard Dawakhana (waqf) Delhi.1981: 90.
14. Anonymous. Qarabadeen-e-Majeedi, Daftar Jamiya Tibbiya, Delhi YNM : 66, 70.
15. Kamaluddin H. Hamdani. Ila- bil-Tadbeer.1st Edition, Ejaz Publishing House, Darya Ganj, New Delhi, 2004; 28-31.
16. Sameena Firdaus, Dr. Ferasat ali, Nida sultana, Sana sultana, Riyazat (Exercise): A Part of Ilaj Bil Tadbeer and its Role in Prevention of Diseases, International Journal of Development Research, 2006; 6(1): 6486-6498.
17. Tavares, F. A. G., Chaves, T. C., Silva, E. D., Guerreiro, G. D., Gonçalves, J. F., & Albuquerque, A. A. A. de. Immediate effects of joint mobilization compared to sham and control intervention for pain intensity and disability in chronic low back pain patients: randomized controlled clinical trial. Revista Dor, 2017:18(1). https://doi.org/10.5935/1806-0013.20170002
18. Chang, W.-D., Lin, H.-Y., & Lai, P.-T. Core strength training for patients with chronic low back pain. Journal of Physical Therapy Science, 27(3) 2015: 619-622. https://doi.org/10.1589/jpts.27.619 PMid:25931693 PMCid:PMC4395677
19. Chen, H.-M., Wang, H.-H., Chen, C.-H., & Hu, H.-M. (). Effectiveness of a Stretching Exercise Program on Low Back Pain and Exercise Self-Efficacy Among Nurses in Taiwan: A Randomized Clinical Trial. Pain Management Nursing, 15(1) 2014: 283-291. https://doi.org/10.1016/j.pmn.2012.10.003 PMid:23266331
20. Hecimovich, M., Pomije, M., & Harbaugh, A. Comparing lumbopelvic stabilization exercises and yoga on functional stability and low back pain in young, non-elite, female gymnasts. Physiotherapy and Health Activity, 25(1), 2018: 1-8 https://doi.org/10.1515/pha-2017-0001
21. Standardization of single drug of unani medicine. Part 2, CCRUM- New Delhi -June 1992: 158-163
22. Kabiruddin H. Makhzanul Mufridat. New Delhi: Aijaz Publishing House; (YNM): 49-52
23. Sighi M, Purohit AA. Studies on comparative larvicidal efficacy of methanol extracted latex of Calotropis procera and Temephos against Aedes aegypti in arid parts of Rajasthan. RJPBCS, 4(4), 2013 :1139-1142.
24. Ghani NM. Khazain al-Advia. Idara Kitab-us-shifa. New Delhi 2011;211,869,549.
25. Funk JL, Frye JB, Oyarzo JN, Timmermann BN. Comparative Effects of Two Gingerol-Containing Zingiber officinale Extracts on Experimental Rheumatoid Arthritis. J Nat Prod. 2009; 72:403-407. https://doi.org/10.1021/np8006183 PMid:19216559 PMCid:PMC2837120
26. Ma J, Jin X, Yang L and Liu ZL. Diarylheptanoids from the rhizomes of Zingiber officinale. Phytochemistry. 2004;65(8): 1137-1143. https://doi.org/10.1016/j.phytochem.2004.03.007 PMid:15110695
27. Yamahara J, Miki K, Chisaka T, Sawada T, Fujimura H, Tomimatsu T, Nakano K, and Nohara T. Cholagogic effect of ginger and its active constituents. J Ethnopharmacol. 1985;13(2):217-225 https://doi.org/10.1016/0378-8741(85)90009-1 PMid:4021519
28. Khan MA. Muheet e Azam (Urdu Translation), CCRUM, New Delhi 2012; 1:577-578.
29. Muniappan M., Sundararaj T. Antiinflammatory and antiulcer activities of Bambusa arundinacea. J. Ethnopharmacolgy. 2003; 88 : 161- 167. https://doi.org/10.1016/S0378-8741(03)00183-1 PMid:12963137
30. Rathod JD. Ameliorative effect of Bambusa arundinacea against adjuvant arthritis-with special reference to bone erosion and tropical splenomegaly. Journal of Drug Delivery and Therapeutics 2012, 2(3). https://doi.org/10.22270/jddt.v2i3.150
31. Bukhari IA, Pivac N, Alhumayyd MS, Mahesar AL, Gilani AH. The analgesic and anticonvulsant effects of piperine in mice. See comment in PubMed Commons below J PhysiolPharmacol 2013: 64: 789-794
32. Bang JS, Oh da H, Choi HM, Sur BJ, Lim SJ, et al. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models. See comment in PubMed Commons below Arthritis Res Ther 2009:11: R49 https://doi.org/10.1186/ar2662 PMid:19327174 PMCid:PMC2688199
33. Kravchenko I, Eberle L, Nesterkina M, Kobernik A. Anti-inflammatory and analgesic activity of ointment based on dense ginger extract (Zingiber officinale). Journal of Herbmed Pharmacology. 2019 Feb 25;8(2):126-32. https://doi.org/10.15171/jhp.2019.20